<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30234689</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>11</Month>            <Day>05</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>05</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1473-5628</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>39</Volume>                    <Issue>11</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Nov</Month>                    </PubDate>                </JournalIssue>                <Title>Nuclear medicine communications</Title>                <ISOAbbreviation>Nucl Med Commun</ISOAbbreviation>            </Journal>            <ArticleTitle>The feasibility of using 18F-FDG-PET/CT in patients with mucinous breast carcinoma.</ArticleTitle>            <Pagination>                <MedlinePgn>1033-1038</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1097/MNM.0000000000000910</ELocationID>            <Abstract>                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">This study investigated the correlation between fluorine-18-fluorodeoxyglucose (F-FDG)-PET/computed tomography (CT) and clinicopathological factors in patients with mucinous breast carcinoma and assessed the feasibility of using F-FDG-PET/CT in evaluating tumors.</AbstractText>                <AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">We retrospectively examined 42 consecutive patients with pathologically proven mucinous breast carcinoma who preoperatively underwent F-FDG-PET/CT. In addition, we compared F-FDG uptake with clinicopathological characteristics.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">F-FDG uptake was observed in 39 (92.9%) lesions. The maximum standardized uptake value (SUVmax) (mean±SD) of all mucinous carcinoma, pure type, and mixed type was 2.3±1.3 (range: 1.0-5.1), 1.9±0.9 (range: 1.0-3.5), and 3.2±1.3 (range: 1.4-5.1), respectively. The mixed type had a significantly higher F-FDG uptake than the pure type (P=0.006). In addition, the sensitivity, specificity, accuracy, and area under the curve for distinguishing the pure type from the mixed type were 61.5, 89.7, 81.0, and 0.76, respectively (cutoff value: SUVmax&gt;3.0). Furthermore, SUVmax correlated significantly with the high nuclear grade (P=0.010) and the presence of axillary lymph node metastasis (P=0.017).</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">F-FDG uptake efficiently distinguishes the pure type from the mixed type and may play a potential role in predicting the aggressiveness of mucinous breast carcinoma.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Fujioka</LastName>                    <ForeName>Tomoyuki</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Departments of Radiology.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kubota</LastName>                    <ForeName>Kazunori</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Departments of Radiology.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kikuchi</LastName>                    <ForeName>Yuka</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Departments of Radiology.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tsuchiya</LastName>                    <ForeName>Junichi</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Departments of Radiology.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tateishi</LastName>                    <ForeName>Ukihide</ForeName>                    <Initials>U</Initials>                    <AffiliationInfo>                        <Affiliation>Departments of Radiology.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kasaharak</LastName>                    <ForeName>Mai</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Surgery, Breast Surgery, Tokyo Medical and Dental University, Tokyo, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Oda</LastName>                    <ForeName>Goshi</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Surgery, Breast Surgery, Tokyo Medical and Dental University, Tokyo, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ishiba</LastName>                    <ForeName>Toshiyuki</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Surgery, Breast Surgery, Tokyo Medical and Dental University, Tokyo, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Nakagawa</LastName>                    <ForeName>Tsuyoshi</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Surgery, Breast Surgery, Tokyo Medical and Dental University, Tokyo, Japan.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Nucl Med Commun</MedlineTA>            <NlmUniqueID>8201017</NlmUniqueID>            <ISSNLinking>0143-3636</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0Z5B2CJX4D</RegistryNumber>                <NameOfSubstance UI="D019788">Fluorodeoxyglucose F18</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D019788" MajorTopicYN="Y">Fluorodeoxyglucose F18</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009092" MajorTopicYN="N">Mucous Membrane</DescriptorName>                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000072078" MajorTopicYN="Y">Positron Emission Tomography Computed Tomography</DescriptorName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>21</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>11</Month>                <Day>6</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>21</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30234689</ArticleId>            <ArticleId IdType="doi">10.1097/MNM.0000000000000910</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>